Pharmaceutical Grade 1190307-88-0 Sofosbuvir Bakeng sa Phekolo ea Hepatitis C
Sehlahisoalebitso | Sofosbuvir |
Litlhaloso tse tšoanang | N-[[P(S),2'R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977 |
Nomoro ea CAS. | 1190307-88-0 |
Ponahalo | Phofo e tšoeu kapa e bosoeu e phatsima |
Foromo ea limolek'hule | C22H29FN3O9P |
Boima ba Molek'hule | 529.45 |
Tšebeliso | Sepheo sa lipatlisiso |
Ho paka | Joalo ka kopo ea hau |
Polokelo | Boloka ka lijaneng tse thata, tse sa keneleng khanya sebakeng se phodileng |
Sofosbuvir Cas: 1190307-88-0 | ||
Lintho | Standard | Liphetho |
Ponahalo | Phofo e tšoeu kapa e bosoeu e phatsima | E lumellana |
Boitsebiso | Nako ea ho boloka tlhoro ea mantlha ea tharollo ea sampole e lumellana le ea tharollo e tloaelehileng, joalo ka ha e fumanoe tlhahlobong ea Assay. | E lumellana |
Ho qhibilihantlha | 118.0 ℃-128.0 ℃ | 121.9 ℃-123 ℃ |
Tahlehelo ka ho omisa | NMT 0.5% | 0.16% |
Mesaletsa ha e tuka | NMT 0.2% | 0.16% |
Metsi | NMT 0.5% | 0.10% |
Bohloeki ba Chiral | The Rp-isomer: NMT 0.2% | 0.01% |
Ntho e amanang le yona | Tšilafalo A: NMT 0.2%Tšilafalo B: NMT 0.1% Tšilafalo C: NMT 0.1% Tšilafalo efe kapa efe: NMT 0.2% Kakaretso ea litšila: NMT 1.0% | 0.03%Ha e fumanwe Ha e fumanwe 0.04% 0.16% |
Tlhahlobo | 98.0%~102.0% | 98.78% |
Residual Solvent | Tetrahydrofuran: NMT 720ppmDichloromethane: NMT 600ppm | 0ppm0ppm |
Qetello:e tsamaellana le maemo a ka tlung. |
Lintlha tsa Khampani
√ Boiphihlelo bo felletseng ba Management layer ho balateli ba lifeme le litsebi tse nang le boiphihlelo; √ Boleng ke kamehla ho nahanela rona holimo, Strict QC tsamaiso; √ lilemo tse 11 tse nang le boiphihlelo sehlopheng sa thekiso ea thepa kantle ho naha; √ Lab e ikemetseng ya R&D; √ Lithupelo tse peli tsa nako e telele tsa GMP; √ Lisebelisoa tse ruileng tsa lifeme tse ngata tse sa sebetseng bakeng sa morero o hlophisitsoeng; √ Sehlopha se sebetsang se sebetsang hantle se nang le tsela e tsitsitseng.Ngola molaetsa wa hao mona mme o re romele wona